NEW YORK (360Dx) – British diagnostics firm Owlstone Medical announced today that it has signed an agreement to provide breath biomarker services to 4D Pharma to assist with its drug-development efforts.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.